Followers | 408 |
Posts | 58829 |
Boards Moderated | 4 |
Alias Born | 05/01/2010 |
Tuesday, April 16, 2024 9:58:58 AM
Quote:
Section 404: Weighted Average Price/Special Pricing Formula Transactions
Q404.1: Member BD1 executes multiple trades to satisfy a customer order and then trades with the customer at a price equal to the volume-weighted average cost of the original trades plus a net difference in accordance with a net trading agreement with its customer. How should BD1 report the trade with its customer?
A404.1:The original trades and the customer leg of the transaction should be reported to the tape, and the report of the customer leg should include the weighted average price (.W) modifier. For example, member BD1 receives an order from a customer to buy 5,000 shares of ABCD security and accumulates the shares through five separate trades. Each of these five trades is reported to the tape. BD1 then sells the 5,000 shares of ABCD to its customer at its volume-weighted average cost with a net difference to reflect the compensation agreement between BD1 and its customer. BD1 should report the sale of 5,000 shares to its customer to the tape with the weighted average price modifier.
Recent TPTW News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 07:43:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/25/2024 04:15:11 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/10/2024 06:46:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 02:03:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 03:02:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/25/2024 06:39:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 04:40:08 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/12/2024 05:39:45 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/17/2024 01:26:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 05:52:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 09:17:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/28/2024 02:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:18:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/10/2024 09:24:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 07:47:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2024 06:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:52:34 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM